Global Orthokeratology Industry Set to Soar with a 7.3% CAGR, Projected to Reach US$ 88.7 Million by 2028 | Unveils FMI

The Global Orthokeratology Industry is on the verge of unprecedented expansion, with a projected valuation of US$ 58.1 million in 2022, soaring to an impressive US$ 88.7 million by 2028. This remarkable growth trajectory is fueled by a robust Compound Annual Growth Rate (CAGR) of 7.3% from 2022 to 2028.

The Orthokeratology market, a key player in the vision care industry, is witnessing a transformative journey toward unparalleled success. The forecasted valuation signifies not only financial prosperity but also underscores the industry’s commitment to advancing eye care solutions globally.

This robust market expansion is attributed to several pivotal factors that have been instrumental in driving the Global Orthokeratology Industry forward:

1. Advancements in Vision Correction: The market is witnessing substantial advancements in implantable vision correction techniques, bolstered by evolving regulatory frameworks and increased reimbursement for corrective procedures that adhere to industry standards.
2. Rising Prevalence of Myopia and Chronic Eye Conditions: The escalating prevalence of myopia and chronic eye conditions, including diabetic retinopathy, is a significant driver behind the market’s growth, as orthokeratology offers an effective solution to these concerns.
3. Growing Patient Awareness: There is a notable increase in patient awareness about Ortho-K, with information readily available through online channels. Moreover, the recent years have seen a noteworthy improvement in the success rates of orthokeratology lenses, further fueling market growth.
4. Emphasis on Healthy Lifestyles: The market’s growth is also influenced by a global emphasis on promoting healthy lifestyles, providing individuals with greater opportunities for well-being through orthokeratology’s non-invasive and effective vision correction solutions.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-3142

Additionally, the high prevalence of chronic diseases like diabetic retinopathy is expected to positively influence the market prospects. Developments such as the emergence of ingenious orthokeratology products and of implantable intraocular lenses will bolster the future possibilities for the orthokeratology market.

Though the orthokeratology industry looks forward to an overall healthy future market prospects, it is not without its share of restraints. The high initial cost of orthokeratology lenses, increasing cases of corneal infection in pediatric patients, less market penetration of the product along a lack of skilled professionals are factors that may subdue the growth of the orthokeratology market over the forecast period.

“High incidences of myopia and better benefits of Ortho-K lens as compared to the conventional ones are likely to boost the sales of orthokeratology in the global market over the forecast period,” says an FMI analyst.  

Global Orthokeratology Industry Key Takeaways:

• High initial costs of the lenses may hinder market growth.
• The US to account for a major share of market revenue by 2028.
• The orthokeratology industry in China will record a high CAGR over the forecast period.
• By indication, the myopia segment will continue to be a major market driver.
• Based on distribution channels, optometry clinics will register the highest demand.

Shedding light on the study’s key assumptions. From Experts.
https://www.futuremarketinsights.com/ask-question/rep-gb-3142

Global Orthokeratology Industry Competitive Landscape 

The Cooper Companies Inc., Euclid Systems Corporation, Menicon Co., Ltd., GP Specialists, Inc., TruForm Optics, Inc., Art Optical Contact Lens, Inc., MiracLens L.L.C., and Contex, Inc., among others, are some of the major players in the orthokeratology market that are profiled in the full version of the report.

Major market players are focused on establishing a stronghold in China and Japan. Mergers and collaborations are certain tactics that these businesses employ to retain a competitive advantage.

More Insights into the Global Orthokeratology Industry Report

In its latest report, FMI offers an unbiased analysis of the global orthokeratology industry, providing historical data from 2013 to 2021 and forecast statistics for 2022 to 2028. To understand the global market potential, growth, and range, the market is segmented based on indication (myopia, presbyopia, hyperopia, astigmatism), distribution channel (hospitals, optometry clinics, ophthalmology clinics), and region.

According to the latest FMI reports, based on region, the orthokeratology industry in the United States is expected to undergo significant growth over the forecast period. The region is predicted to acquire a major chunk of the global market share by 2028. This growth can be attributed to the presence of a well-developed and established healthcare sector. Favorable government initiatives in the healthcare sector also support this market growth.

In China, the orthokeratology market is projected to exhibit a high CAGR over the forecast period. The region is expected to offer multiple lucrative opportunities to the orthokeratology industry. Prolonged usage of electronic devices such as laptop, smartphones, tablets, etc., has led to high rates of chronic eye damage. With high prevalence of myopia and hyperopia, the target market in China is expected to grow at a rapid rate.

Based on segmentation, by indication, the myopia segment will likely create substantial market opportunities while, in terms of distribution channels, optometry clinics will dominate the market over the forecast period.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/3142

Key Segments Covered in Global Orthokeratology Industry Survey

Global Orthokeratology Industry by Indication:

• Myopia
• Presbyopia
• Hyperopia
• Astigmatism

Global Orthokeratology Industry by Distribution Channel:

• Hospitals
• Optometry Clinics
• Ophthalmology Clinics

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube